Jade Biosciences
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -9 | -9 | -12 |
EBITDA | -40,343 | -31,865 | -25,163 |
EBIT | -40,352 | -31,874 | -25,175 |
Net Income | -40,368 | -31,932 | -25,175 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -24,081 | -33,652 | -22,181 |
Cash | 55,085 | 88,438 | 50,106 |
Basic Shares | 57,777 | 49,316 | 39,584 |
Annual Financials
| Values in thousands | 2025-12-31 |
|---|---|
Revenue | $0 |
Gross Profit | -26 |
EBITDA | -127,326 |
EBIT | -127,352 |
Net Income | -127,410 |
Net Change In Cash | 0 |
Free Cash Flow | -94,885 |
Cash | 88,438 |
Basic Shares | 31,359 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.76 |
2026-03-31 | -$0.57 |
2025-09-30 | -$0.48 |
2025-06-30 | -$0.86 |